7 Result(s)
within
Mai-Szu Wu
Internal Medicine
-
Article
Open AccessGlobal Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme
Chronic kidney disease (CKD) is a progressive disease of growing prevalence, posing serious concerns for global public health. While the economic burden of CKD is substantial, data on the cost of CKD is limite...
-
Article
Open AccessEnterobius vermicularis infection: prevalence and risk factors among preschool children in kindergarten in the capital area, Republic of the Marshall Islands
Enterobius vermicularis (pinworm) is one of the most common human parasitic helminths, and children are the most susceptible group. Some behavioral and environmental factors may facilitate pinworm infection. In t...
-
Article
Open AccessAssociation of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients
Infection is the second most common cause of mortality for patients with end-stage renal disease (ESRD), accompanying with immune dysfunction. Endothelin (EDN) is known to be related to inflammation; however, it ...
-
Article
Open AccessAssociations of genetic variants of endothelin with cardiovascular complications in patients with renal failure
Cardiovascular (CV) complications are the main cause of death in end-stage renal disease (ESRD) patients. The high CV risks are attributable to the additive effects of multiple factors. Endothelin (EDN) is a p...
-
Article
Open AccessFactors associated with chronic musculoskeletal pain in patients with chronic kidney disease
Chronic musculoskeletal (MS) pain is common in patients with chronic kidney disease (CKD) undergoing haemodialysis. However, epidemiological data for chronic MS pain and factors associated with chronic MS pain...
-
Article
Open AccessRe-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels — a four-years prospective cohort study in Taiwan
Metabolic complications are associated with clinical outcomes in patients with chronic kidney disease (CKD). These outcomes differ among patients according to the different stages of disease. The prevalence an...
-
Article
Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury—beyond the direct renin inhibition
Chronic renal ischemia leads to renal fibrosis and atrophy. Activation of the renin-angiotensin–aldosterone system is one of the main mechanisms driving chronic renal ischemic injury. The aim of the present st...
